7336-54-1 Usage
Uses
Used in Pharmaceutical Industry:
2-Acetamido-5-bromothiazole is used as a synthetic intermediate for the production of various pharmaceuticals, contributing to the development of new drugs and improving the efficacy of existing ones. Its unique structure and reactivity allow for the creation of bioactive molecules with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-Acetamido-5-bromothiazole is utilized as a key component in the synthesis of agrochemicals, such as pesticides and herbicides. Its incorporation into these compounds can enhance their effectiveness in controlling pests and weeds, thereby improving crop yields and protecting agricultural resources.
Used in Research and Development:
2-Acetamido-5-bromothiazole is employed as a research compound in the development of new materials and organic compounds. Its unique properties make it a valuable tool for scientists and researchers working on innovative projects in various fields, including chemistry, biology, and materials science.
Used in Drug Synthesis:
2-Acetamido-5-bromothiazole is used as a building block in the synthesis of various drugs, particularly those with therapeutic applications. Its presence in the molecular structure of these drugs can enhance their pharmacological properties, such as potency, selectivity, and bioavailability, leading to improved treatment outcomes for patients.
Check Digit Verification of cas no
The CAS Registry Mumber 7336-54-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,3 and 6 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7336-54:
(6*7)+(5*3)+(4*3)+(3*6)+(2*5)+(1*4)=101
101 % 10 = 1
So 7336-54-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H5BrN2OS/c1-3(9)8-5-7-2-4(6)10-5/h2H,1H3,(H,7,8,9)
7336-54-1Relevant academic research and scientific papers
PYRAZOLOPYRIMIDINE DERIVATIVE AND USE THEREOF AS PI3K INHIBITOR
-
Paragraph 0176-0178, (2021/06/03)
The present invention discloses a series of pyrazolopyrimidine derivatives and use thereof in preparing a medicament for treating a disease related to PI3K, and in particular, discloses a derivative compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof.
Thiazole compounds and methods of use
-
Page/Page column 30; 31, (2008/06/13)
The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
NOVEL COMPOUNDS THAT MODULATE PPARγ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
-
Page 60, (2008/06/13)
The invention relates to novel compounds corresponding to the general formula (I) below: (I) and also to the method for preparing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism),-or alternatively in cosmetic compositions.
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
-
, (2008/06/13)
Compounds of the formula and pharmaceutically acceptable salts thereof are provided.